Stay updated on Pembrolizumab Plus Lenvatinib Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.

Latest updates to the Pembrolizumab Plus Lenvatinib Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedEnrollment status updated to show completion and no longer recruiting. New help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) plus a revision tag (v3.6.0) were added, and the Intervention/Treatment header formatting was standardized.SummaryDifference0.2%

- Check20 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a newer version of the page. This metadata update does not alter the study details or visible content.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing v3.5.3. This represents a routine page revision without changes to the study data or on-page sections describing the trial.SummaryDifference0.0%

- Check48 days agoChange DetectedAdds a new LEAP-005 publication entry detailing results for gastric, biliary tract, and pancreatic cancers to the Publications section. Removes several 2025 postings from Publications, updating the record with newer citations.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page’s interface revision/version label was updated to a newer revision (v3.5.3) without changing the underlying study details shown on the record.SummaryDifference0.0%

- Check70 days agoChange DetectedAdded Temuco, Araucania, Chile, 4780000 as a new site and removed Temuco, Región de la Araucanía, Chile, 4780000, updating the region name from Región de la Araucanía to Araucania. Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Plus Lenvatinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.